Diabetic Retinopathy

Roche drops eye drug, exits solid tumor field

Roche abandons oral drug for eye disease after phase 2 failure, shifts focus from solid tumor bispecifics

Anika Sharma

Roche’s ambitious quest to develop an oral treatment for diabetic retinopathy has faced a setback, as the company decided to ...

Eylea, Regeneron Pharmaceuticals, Wet Age-related Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, FDA approval

FDA Approves Eylea HD Injection 8 mg for the Treatment of Wet Age-related Macular Degeneration, Diabetic Macular Edema, and Diabetic Retinopathy

Anika Sharma

On August 18, 2023, Regeneron Pharmaceuticals announced a groundbreaking development in the field of ophthalmology: the US Food and Drug ...